Strasbourg (France), Tokyo (Japan) and Waltham, Mass, Mar 5, 2024 - (JCN Newswire) - Transgene (Euronext Paris: TNG), a biotech company that designs and...

Part 2 of the Phase 2/3 SIGLEC clinical trial is designed and powered to serve as the first pivotal trial to support approval of...

LONDON, Jan 15, 2024 - (ACN Newswire) - A new international biotech group was born from the integration of Hyris Ltd, an innovative biotech company renowned worldwide for...

Strasbourg, France & Tokyo, Japan, Jan 9, 2024 - (JCN Newswire) - Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based...

– Achieved Full Year 2023 Preliminary Global Net Product Revenues of $1,241 Million for ONPATTRO®, AMVUTTRA®, GIVLAARI®, and OXLUMO®, Representing 39% Annual Growth (39%...

Up against an onslaught of lawsuits, 23andMe is denying liability for millions of users' genetic records leaked last fall.In a letter sent to a...

CRISPR ended 2023 with a bang.In November, the gene editing tool scored its first clinical approval for treating sickle cell anemia and beta-thalassemia in...

Google DeepMind Used a Large Language Model to Solve an Unsolvable Math ProblemWill Douglas Heaven | MIT Technology Review“In a paper published in Nature...

<!-- -->The healthcare industry is facing several challenges, including rising costs, increasing complexity, and a growing demand for personalized treatment....

Award Recognizes BostonGene for Commitment to Innovation and the Profound Impact of AI-driven Solutions WALTHAM, Mass–(BUSINESS WIRE)–BostonGene, a leading provider of AI-driven, molecular and immune...

CER-001 treatment attenuated systemic inflammation, downregulated Indoleamine-2,3-dioxygenase (IDO1) thereby reducing neuroactive metabolites and waste accumulation Preclinical data support the concept that the use of CER-001...

– Zilebesiran Met Primary Endpoint Demonstrating Up to 16.7 mmHg Placebo-Adjusted Reduction of 24-Hour Mean Systolic Blood Pressure at Three Months of Treatment – –...